Effective June 6, 2019, the Board of Directors of NanoViricides, Inc. appointed Mark Day, Ph.D., as a new member of the Board. Dr. Day is an Independent Member of the Board of Directors, and will serve as a member of the Company's Audit, Compensation and Nominating Committees. Mark Day, PhD., has almost twenty years' experience in R&D and business development in the biotech industry. From April 2017 to March 2019, Dr. Day served as the President, Chief Executive Officer and a Director of Bioasis Technologies, Inc.